CAR T cells ready to go mainstream

被引：0
|
作者：
Diana Romero
机构：
来源：
Nature Reviews Clinical Oncology | 2016年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：397 / 397
相关论文
共 50 条
  • [1] CAR T cells ready to go mainstream
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (07) : 396 - 397
  • [2] CAR T Cells for Solid Tumors Armed and Ready to Go?
    Kakarla, Sunitha
    Gottschalk, Stephen
    CANCER JOURNAL, 2014, 20 (02): : 151 - 155
  • [3] CAR T-cells for colorectal cancer immunotherapy: Ready to go?
    Ghazi, Bouchra
    El Ghanmi, Adil
    Kandoussi, Sarah
    Ghouzlani, Amina
    Badou, Abdallah
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] "Are They Ready Yet?": release criteria for autologous CAR T cells
    Jallouk, Andrew P.
    Oluwole, Olalekan
    Dholaria, Bhagirathbhai
    BONE MARROW TRANSPLANTATION, 2025, : 429 - 430
  • [5] Shared target antigens on cancer cells and tissue stem cells: go or no-go for CAR T cells?
    Hombach, Andreas A.
    Abken, Hinrich
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (02) : 151 - 155
  • [6] CAR T-Cells in Multiple Myeloma Are Ready for Prime Time
    Rodriguez-Otero, Paula
    Prosper, Felipe
    Alfonso, Ana
    Paiva, Bruno
    San Miguel, Jesus F.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 16
  • [7] LiFi is Ready for Mainstream
    Banham, A.
    Schaeffer, R.
    Scace, S.
    2021 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXPOSITION (OFC), 2021,
  • [8] Are we ready for personalized CAR-T therapy?
    Strzelec, Anna
    Helbig, Grzegorz
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 174 - 183
  • [9] CAR T-cells for pediatric solid tumors: where to go from here?
    Trautmann, Tina
    Yakobian, Natalia
    Nguyen, Rosa
    CANCER AND METASTASIS REVIEWS, 2024, : 1445 - 1461
  • [10] BCMA CAR-T cells in multiple myeloma-ready for take-off?
    Scheller, Lukas
    Tebuka, Erius
    Rambau, Peter Fabian
    Einsele, Hermann
    Hudecek, Michael
    Prommersberger, Sabrina Rebecca
    Danhof, Sophia
    LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 143 - 157
12345